Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2021

Jan 28, 2021

30403_dirs_2021-01-27_be33ac71-7745-4951-aacf-008d5f16bd5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2021-01-25

Reporting Person: Jacobsen Kevin B (EVP - Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-25 Common Stock M 11410.0000 $111.6000 Acquired 26491.0000 Direct
2021-01-25 Common Stock M 10920.0000 $123.0900 Acquired 37411.0000 Direct
2021-01-25 Common Stock M 7372.0000 $135.5700 Acquired 44783.0000 Direct
2021-01-25 Common Stock M 5580.0000 $128.6900 Acquired 50363.0000 Direct
2021-01-25 Common Stock S 35176.0000 $215.0000 Disposed 15187.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-25 Stock Option (Right to Buy) $128.6900 M 5580.0000 Disposed 2028-04-02 Common Stock (5580.0000) Direct
2021-01-25 Stock Option (Right to Buy) $135.5700 M 7372.0000 Disposed 2027-09-12 Common Stock (7372.0000) Direct
2021-01-25 Stock Option (Right to Buy) $123.0900 M 10920.0000 Disposed 2026-09-13 Common Stock (10920.0000) Direct
2021-01-25 Stock Option (Right to Buy) $111.6000 M 11410.0000 Disposed 2025-09-17 Common Stock (11410.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 42.0000 Indirect
Common Stock 25.0000 Indirect
Common Stock 3145.0000 Indirect

Footnotes

F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 8/13/2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.